These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 6115310)

  • 21. [Carrier detection and genetic counselling in duchenne muscular dystrophy (author's transl)].
    Moser H
    Schweiz Rundsch Med Prax; 1977 Jul; 66(27):814-22. PubMed ID: 896656
    [No Abstract]   [Full Text] [Related]  

  • 22. Three years' experience with neonatal screening for Duchenne/Becker muscular dystrophy: gene analysis, gene expression, and phenotype prediction.
    Greenberg CR; Jacobs HK; Halliday W; Wrogemann K
    Am J Med Genet; 1991 Apr; 39(1):68-75. PubMed ID: 1867267
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Genetic epidemiology and prophylaxis of Duchenne type muscular dystrophy].
    Kondo K
    Nihon Rinsho; 1982; 40(7):1528-33. PubMed ID: 6757480
    [No Abstract]   [Full Text] [Related]  

  • 24. Editorial: Screening of the newborn for Duchenne muscular dystrophy.
    Br Med J; 1975 May; 2(5968):403-4. PubMed ID: 1125555
    [No Abstract]   [Full Text] [Related]  

  • 25. Genetic counselling in neuromuscular diseases in Western Australia.
    Hurse PV; Kakulas BA
    Proc Aust Assoc Neurol; 1974; 11():145-53. PubMed ID: 4469625
    [No Abstract]   [Full Text] [Related]  

  • 26. Duchenne muscular dystrophy: early diagnosis, and screening.
    Arch Dis Child; 1976 Dec; 51(12):982-6. PubMed ID: 1015854
    [No Abstract]   [Full Text] [Related]  

  • 27. [Detection, genetic counseling and phenotype prevention of Duchenne muscular dystrophy].
    Bachmann H; Lössner J; Kühn HJ; Ruchholtz U; Göhler I
    Psychiatr Neurol Med Psychol (Leipz); 1984 Sep; 36(9):537-44. PubMed ID: 6514865
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Editorial: Carrier detection in Duchenne type muscular dystrophy.
    Morgan G
    Aust N Z J Med; 1974 Apr; 4(2):196-7. PubMed ID: 4528526
    [No Abstract]   [Full Text] [Related]  

  • 29. [Identification of the carrier state in the severe recessive X-linked muscular dystrophy (Duchenne type). I. Assay of activated serum creatine kinase activity in serum (author's transl)].
    Rotthauwe HW; Kowalewski S
    Z Kinderheilkd; 1973 Nov; 115(4):333-42. PubMed ID: 4591596
    [No Abstract]   [Full Text] [Related]  

  • 30. Genetic counseling in Duchenne muscular dystrophy.
    Bradley WG; Kelemen J
    Muscle Nerve; 1979; 2(5):325-8. PubMed ID: 492208
    [No Abstract]   [Full Text] [Related]  

  • 31. Duchenne muscular dystrophy: systematic neonatal screening and earlier detection of carriers.
    Plauchu H; Dellamonica C; Cotte J; Robert JM
    J Genet Hum; 1980 Dec; 28(4):65-82. PubMed ID: 7205199
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carrier detection and genetic counselling in Duchenne dystrophy.
    Dubowitz V
    Dev Med Child Neurol; 1975 Jun; 17(3):352-6. PubMed ID: 1107098
    [No Abstract]   [Full Text] [Related]  

  • 33. Screening for Duchenne muscular dystrophy.
    Smith RA; Rogers M; Bradley DM; Sibert JR; Harper PS
    Arch Dis Child; 1989 Jul; 64(7):1017-21. PubMed ID: 2629623
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Screening for Duchenne muscular dystrophy].
    Beckmann R
    Offentl Gesundheitswes; 1981 Sep; 43(9):414-20. PubMed ID: 6213887
    [No Abstract]   [Full Text] [Related]  

  • 35. Impact of genetic counselling after neonatal screening for Duchenne muscular dystrophy.
    Hildes E; Jacobs HK; Cameron A; Seshia SS; Booth F; Evans JA; Wrogemann K; Greenberg CR
    J Med Genet; 1993 Aug; 30(8):670-4. PubMed ID: 8411054
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DUCHEN: an interactive computer program for calculating heterozygosity (carrier) risks in X-linked recessive lethal diseases, and its application in Duchenne muscular dystrophy.
    Andrews DF; Brasher PM; Manchester KE; Percy ME; Rusk AC; Soltan HC; Trueman DW
    Am J Med Genet; 1986 Oct; 25(2):211-8. PubMed ID: 3777018
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sporadic Duchenne muscular dystrophy in females; genetic counseling of women with pelvifemoral muscular dystrophy.
    Zellweger H; Ionasescu V; Simpson J
    Helv Paediatr Acta; 1980 Sep; 35(4):343-8. PubMed ID: 7451237
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Duchenne muscular dystrophy and idiopathic hyperCKemia in a family causing confusion in genetic counselling.
    Bushby K; Goodship J; Haggerty D; Heald A; Walls T
    Am J Med Genet; 1996 Dec; 66(2):237-8. PubMed ID: 8958338
    [No Abstract]   [Full Text] [Related]  

  • 39. [Duchenne-type muscular dystrophy: problems, early diagnosis, early treatment (author's transl)].
    Beckmann R
    Klin Padiatr; 1978 Nov; 190(6):531-9. PubMed ID: 362050
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A study of carrier detection of Duchenne type progressive muscular dystrophy by serum myoglobin measurement (author's transl)].
    Konagaya M; Takayanagi T; Konagaya Y; Sobue I
    Rinsho Shinkeigaku; 1982 Jan; 22(1):30-5. PubMed ID: 7094482
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.